These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29080581)

  • 1. Management of Lipids in Patients with Diabetes.
    Mbue ND; Mbue JE; Anderson JA
    Nurs Clin North Am; 2017 Dec; 52(4):605-619. PubMed ID: 29080581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lipids and type 2 diabetes.
    Hermayer KL
    Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.
    Orloff DG; Blazing MA; O'Connor CM
    Am Heart J; 1999 Nov; 138(5 Pt 1):S406-12. PubMed ID: 10539805
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipids and diabetes mellitus: a review of therapeutic options.
    Goguen JM; Leiter LA
    Curr Med Res Opin; 2002; 18 Suppl 1():s58-74. PubMed ID: 12365820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective care of patients with type 2 diabetes and dyslipidemia: a nurse's perspective.
    Adiseshiah M
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S23-7. PubMed ID: 15953503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
    Dobordzhginidze LM
    Kardiologiia; 2004; 44(3):87-93. PubMed ID: 15489838
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolomics and Lipidomics Profiling Reveals Hypocholesterolemic and Hypolipidemic Effects of Arabinoxylan on Type 2 Diabetic Rats.
    Nie Q; Xing M; Chen H; Hu J; Nie S
    J Agric Food Chem; 2019 Sep; 67(38):10614-10623. PubMed ID: 31483658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UKPDS: implications for the dyslipidaemic patient.
    Holman R
    Acta Diabetol; 2001; 38 Suppl 1():S9-14. PubMed ID: 11829452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse-led risk assessment/management clinics reduce predicted cardiac morbidity and mortality in claudicants.
    Hatfield J; Gulati S; Abdul Rahman MN; Coughlin PA; Chetter IC
    J Vasc Nurs; 2008 Dec; 26(4):118-22. PubMed ID: 19022170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial assessment of lipid-acting drugs in diabetic patients.
    Steiner G
    Am J Cardiol; 1998 Apr; 81(8A):58F-59F. PubMed ID: 9604911
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipids--Diagnosis and therapy in diabetes mellitus].
    Wascher TC; Paulweber B; Toplak H; Säly CH; Drexel H; Föger B; Hoppichler F
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S68-70. PubMed ID: 27052223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in dyslipidemia.
    Burke HB
    Heart Dis; 2002; 4(3):141-6. PubMed ID: 12028597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia. What to do when life-style changes aren't enough.
    Peters WL
    Postgrad Med; 1991 Oct; 90(5):213-7, 220-4. PubMed ID: 1924009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compliance in your dyslipidemic patient: an evidence-based approach.
    Becker DM; Allen JK
    J Am Acad Nurse Pract; 2001 May; 13(5):200-7. PubMed ID: 11930470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [KLAS [Kanazawa Lipid Assessment Survey]].
    Mabuchi H; Inazu A; Higashikata T; Nohara A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():469-76. PubMed ID: 11347115
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
    Haffner S
    Am J Cardiol; 2005 Aug; 96(4A):33E-36E. PubMed ID: 16098841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
    Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.